372 related articles for article (PubMed ID: 21712406)
1. FoxM1: a master regulator of tumor metastasis.
Raychaudhuri P; Park HJ
Cancer Res; 2011 Jul; 71(13):4329-33. PubMed ID: 21712406
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
4. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
5. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
6. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
7. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV
Cancer Res; 2006 Feb; 66(4):2153-61. PubMed ID: 16489016
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
9. Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.
Kopanja D; Pandey A; Kiefer M; Wang Z; Chandan N; Carr JR; Franks R; Yu DY; Guzman G; Maker A; Raychaudhuri P
J Hepatol; 2015 Aug; 63(2):429-36. PubMed ID: 25828473
[TBL] [Abstract][Full Text] [Related]
10. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma.
Bellelli R; Castellone MD; Garcia-Rostan G; Ugolini C; Nucera C; Sadow PM; Nappi TC; Salerno P; Cantisani MC; Basolo F; Gago TA; Salvatore G; Santoro M
Endocr Relat Cancer; 2012 Oct; 19(5):695-710. PubMed ID: 22919068
[TBL] [Abstract][Full Text] [Related]
12. TIS21 negatively regulates hepatocarcinogenesis by disruption of cyclin B1-Forkhead box M1 regulation loop.
Park TJ; Kim JY; Oh SP; Kang SY; Kim BW; Wang HJ; Song KY; Kim HC; Lim IK
Hepatology; 2008 May; 47(5):1533-43. PubMed ID: 18393292
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the master regulator FOXM1 in cancer.
Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
[TBL] [Abstract][Full Text] [Related]
14. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
15. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC.
Calvisi DF; Pinna F; Ladu S; Pellegrino R; Simile MM; Frau M; De Miglio MR; Tomasi ML; Sanna V; Muroni MR; Feo F; Pascale RM
Gut; 2009 May; 58(5):679-87. PubMed ID: 19136513
[TBL] [Abstract][Full Text] [Related]
16. FOX(M1) news--it is cancer.
Halasi M; Gartel AL
Mol Cancer Ther; 2013 Mar; 12(3):245-54. PubMed ID: 23443798
[TBL] [Abstract][Full Text] [Related]
17. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy.
Shi M; Cui J; Xie K
Curr Drug Targets; 2013 Sep; 14(10):1192-202. PubMed ID: 23834153
[TBL] [Abstract][Full Text] [Related]
18. A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.
Gusarova GA; Wang IC; Major ML; Kalinichenko VV; Ackerson T; Petrovic V; Costa RH
J Clin Invest; 2007 Jan; 117(1):99-111. PubMed ID: 17173139
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
[TBL] [Abstract][Full Text] [Related]
20. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
